Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint, Code Amber to Develop Memory Stick to Contain Children's DNA

NEW YORK (GenomeWeb News) — DNAPrint Genomics and Code Amber plan to co-develop and market a memory stick that can store a child’s DNA sequence, the companies said today.
DNAPrint also said it will become a sponsor on the Code Amber Ticker, a news feed that spreads alerts via the Web about missing or endangered children.  
The memory stick would hold DNA sequencing data on a flash memory device that also would contain photographs and other information about the child.
DNAPrint CEO and president Richard Gabriel said the Code Amber agreement is “one of many channels” the company uses to get parents to store their children’s DNA sequence information for identification and medical information.  

Financial terms of the agreement were not released.

Code Amber, based in Mandeville, La., “offers a range of products and services to law enforcement, media, corporations and the public dealing with Amber Alert notification, child safety and information storage.

Code Amber refers to the Amber Alert, a notification to the general public of a confirmed child abduction. The acronym AMBER stands for America's Missing: Broadcasting Emergency Response.” It is also the first name of Amber Hagerman, a 9-year-old who was abducted and murdered in Arlington, Texas, in 1996.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.